MA16.09 Antitumor Activity and Safety of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
Autor: | A. Drilon, Paul K. Paik, Sai-Hong Ou, Jared Weiss, Geoffrey I. Shapiro, Sherry C. Wang, Benjamin Solomon, Rebecca S. Heist, Katherine Monti, Gregory J. Riely, Keith D. Wilner, Mark A. Socinski, Maria Winter, D. Ross Camidge, Jeffrey W. Clark |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine Antitumor activity Oncology medicine.medical_specialty Crizotinib business.industry medicine.disease 03 medical and health sciences Exon 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Cancer research In patient Non small cell Lung cancer business medicine.drug |
Zdroj: | Journal of Thoracic Oncology. 12:S438-S439 |
ISSN: | 1556-0864 |
DOI: | 10.1016/j.jtho.2016.11.512 |
Databáze: | OpenAIRE |
Externí odkaz: |